On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Watching that in Ukraine, a country under fire, the intensity is multiplied. At the start of Russia's full-scale invasion in ...

According to Towards FnB, the global edible offal market size is calculated at USD 45 billion in 2025 and is anticipated to ...

WALTHAM, Mass. and BOULDER, Colo., Nov. 10, 2025 (GLOBE NEWSWIRE) -- (“Cogent”) (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, tod ...

The Q3 2025 dividend will be paid on December 15, 2025 to shareholders of record at the close of business on November 28, 2025.

B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce its operational and financial ...

This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, ...

Achieved record levels of consolidated net revenue, gross profit and Adjusted EBITDANet revenue in Q3 2025 increased by 9% quarter-over-quarter ...

J.P. Morgan, Jefferies, Leerink Partners and Guggenheim Securities are acting as joint-book running managers for the proposed Equity Offering. LifeSci Capital is acting as lead manager and Raymond ...

AZB & Partners has dominated M&A deals in the financial services space while CAM, SAM, Trilegal and JSA fight for market ...

Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the third quarter and nine-month period ended September 30, 2025. Discontinued operations as a ...

For the nine months ended September 30, 2025, LifeStance provided $88.6 million cash flow from operations, including $27.3 million during the third quarter of 2025. The Company ended the third quarter ...